Reference pricing in EU leads to convergence and lower prices, says Strasbourg report
This article was originally published in Scrip
Executive Summary
According to a new independent report commissioned by the European Parliament, European Union countries' use of reference pricing to control drug prices seems to be leading to price convergence for some drugs and, in general, to lower prices.